Sangamo Therapeutics
SGMO
SGMO
187 hedge funds and large institutions have $370M invested in Sangamo Therapeutics in 2022 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 73 increasing their positions, 46 reducing their positions, and 21 closing their positions.
Holders
187
Holders Change
-7
Holders Change %
-3.61%
% of All Funds
3.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
73
Reduced
46
Closed
21
Calls
$2.56M
Puts
$1.54M
Net Calls
+$1.02M
Net Calls Change
-$672K
Top Buyers
1 |
RCM
1
Rokos Capital Management
London,
United Kingdom
|
$12.5M |
2 |
WA
2
Wasatch Advisors
Salt Lake City,
Utah
|
$51.3M |
3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$47.7M |
4 |
CC
4
Casdin Capital
New York
|
$4.14M |
5 |
5
BlackRock
New York
|
$51.2M |